Clinical Trial Update: A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for IDE892 evaluating monotherapy and combination in MTAP-deleted advanced solid tumors. The study is currently recruiting across …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Esophageal Squamous Cell Carcinoma
• Gastric Adenocarcinoma
• Non-small Cell Lung Cancer
• Peritoneal Mesothelioma
• Pleural Mesothelioma
• Urothelial Carcinoma

Drugs mentioned

• IDE892

Snippet

Sponsor: IDEAYA Biosciences | Conditions: NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC) | Phase 1 | Status: RECRUITING